CMS released the Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) proposed rule, CMS-6098-P, on November 16, and Medicare Advantage sits at the center of the projected savings. CMS estimates the full rule would save nearly $90 billion over 10 years across Medicare, Medicaid, CHIP and the Marketplace, and its RADV proposal alone accounts for an estimated $9 billion per payment year in collections from MA organizations. The 60-day comment period opens with Federal Register publication this week.
What CRUSH is and where the rule stands
CRUSH is a standalone, discretionary program integrity rule, separate from the annual payment rules, and CMS plans to issue program integrity rulemaking of this kind every year going forward. Nothing in the proposal is in effect. CMS will accept comments for 60 days after Federal Register publication, a window trade coverage puts at January 19, 2027, and the agency will weigh those comments before issuing a final rule on an unannounced timeline.
The 545-page proposal spans provider enrollment, MA and Part D oversight, Medicaid and CHIP eligibility, DMEPOS suppliers and Marketplace agents and brokers. This article covers the four provisions with the most direct reach into Medicare Advantage and managed care, drawing on the CMS fact sheet and the proposed rule text.
RADV extrapolation returns to rulemaking
The largest dollar item is RADV. CMS proposes to extrapolate audit findings starting with payment year 2018 audits, to codify the absence of a fee-for-service (FFS) adjuster and to determine the sampling methodology itself. CMS estimates the change would collect an average of about $9 billion per payment year, and the proposed rule's executive summary ties the RADV reforms to an estimated $21 billion per year in MA overpayments from inflated risk scores.
The policy is familiar. CMS finalized extrapolation from PY 2018 without an FFS adjuster in its 2023 RADV final rule, and in September 2025 the U.S. District Court for the Northern District of Texas vacated the 2023 rule in Humana v. Becerra on procedural grounds under the Administrative Procedure Act, without ruling on extrapolation or the adjuster themselves. The government appealed in November 2025. CRUSH puts the same policy through notice and comment again, which gives plans, actuaries and trade groups a formal opening to weigh in on the FFS adjuster question before any final rule.
The proposal also writes RADV hardship exceptions into regulation for the first time. Today the process lives only in subregulatory guidance, and CMS would define the extraordinary circumstances under which a plan qualifies for an exception to medical record submission, with the stated goal of more consistency and transparency.
The proposal arrives while the audit program already runs at scale. CMS's RADV team told attendees at The 27th Risk Adjustment Forum in October the PY 2024 audit covers 590 contracts, with PY 2023 and PY 2022 next on the schedule, as we covered in How CMS is scaling RADV audits. Extrapolation from PY 2018 forward applies audit findings across a full contract and back across several payment years, and many risk-bearing provider contracts pass RADV adjustments downstream, so the final version of this provision reaches beyond the plan itself.
Providers billing MA would need Original Medicare enrollment
Proposed § 422.222(a) would require every eligible provider and supplier billing MA to be enrolled in Original Medicare in an approved status, with PACE excepted. Enrollment carries the full Original Medicare screening process, including identity verification, licensure review, site visits and fingerprint-based background checks. CMS proposes a start date of the first day of the plan year beginning two years after the final rule is published.
For providers already enrolled in an approved status, nothing changes. The attention falls on clinicians and suppliers outside Original Medicare enrollment, such as those who see only MA members or whose enrollment has lapsed or sits in a pending status. For your network management and credentialing teams, the requirement adds a federal enrollment check alongside the credentialing your plan already performs, and risk-bearing provider groups, IPAs and MSOs face the same check for the clinicians under their contracts.
Fraud referrals move from voluntary to required
MA organizations and Part D sponsors are encouraged today to refer suspected fraud, waste and abuse to CMS. CRUSH would require referrals of substantiated or suspicious activity, and would expand required reporting of payment suspensions based on credible allegations of fraud from pharmacies to all provider and supplier types. CMS's fact sheet sets the baseline: for CY 2025, 46 percent of Part C and D contracts voluntarily reported referrals, and 19 percent reported any payment suspensions. The proposal traces back to a July 2018 OIG recommendation for centralized reporting of Part C and D fraud incidents, and for plans already referring cases, the change formalizes current practice.
Medicaid managed care plans would report member changes within 30 days
Medicaid managed care plans would report beneficiary deaths and address changes within 30 days and return overpayments attributable to members who have died or moved out of state. The provision sits alongside the rule's other Medicaid and CHIP eligibility changes.
When each provision would take effect
The calendar runs in stages. Comments close 60 days after Federal Register publication, reported as January 19, 2027, and CMS then issues a final rule on an unannounced schedule. RADV extrapolation, mandatory fraud referrals and the Medicaid reporting provisions would apply upon finalization, while the MA enrollment requirement starts later. A final rule published in mid-2027, for example, would put the enrollment start date at January 1, 2030.
Comments from plans, providers, actuaries and vendors over the next two months will show where the industry wants CMS to revisit its approach, and the final rule will show how much of the proposal survives.
Risk adjustment and program integrity, compliance and audit readiness, and provider partnerships and value-based care are focuses at RISE National 2027, March 16 to 18 at Caesars Forum in Las Vegas, where plan, provider and vendor leaders meet to discuss where CRUSH stands after the comment period closes.
Sources
CMS, CRUSH proposed rule, Federal Register public inspection document 2026-23461.
Crowell & Moring, Court vacates CMS's 2023 final rule on RADV audits (Sept. 26, 2025).
Crowell & Moring, CMS appeals Humana v. Becerra (Nov. 2025).
Medical Daily, CMS CRUSH rule would expand Medicare Advantage audits (Nov. 2026).